CDC affirms value of COVID booster shots

Special to Atmore News

The January 28 Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention (CDC) affirmed the value of COVID-19 booster doses in preventing infections and deaths from COVID-19.
The report states that during the periods of Delta and Omicron variant emergence, COVID-19 vaccination protected against both variants. Even though COVID-19 vaccine effectiveness decreased with the emergence of the Delta variant and vaccine-induced immunity waned, protection against hospitalization and death has remained high.
Unvaccinated adults had a five times higher risk of infection compared with adults who were fully vaccinated with a booster.
Alabama was included in the 25 jurisdictions that participated in the research: Alabama, Arkansas, California, Colorado, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), Rhode Island, Seattle / King County (Washington), Tennessee, Texas, Utah, and Wisconsin.
All eligible persons are advised to stay up to date with COVID-19 vaccinations. Three COVID-19 vaccines are authorized or approved for use in the United States to prevent COVID-19. Pfizer-BioNTech or Moderna (COVID-19 mRNA vaccines) are preferred.
Moderna announced Monday that its vaccine has full Food and Drug Administration approval for adults age 18 and older. The Johnson & Johnson / Janssen COVID-19 vaccine can be given in some situations.
For more information about booster shots and when they should be received, visit
To locate a vaccination site near you, visit The study can be viewed at
COVID-19 advice
*Be sure to get tested for COVID-19
*If you have symptoms of COVID-19, visit or locate a testing site.
Free at-home tests
You may also order free home tests from The State Health Officer has issued a standing order for over-the-counter home COVID-19 tests that have been issued an emergency use authorization or are approved by the U.S. Food and Drug Administration.
While a prescription is not required to purchase over-the-counter tests, this standing order can be used as a prescription by licensed pharmacists in Alabama if needed.
Every home in the U.S. is eligible to order four at-⁠home COVID-⁠19 tests. The tests are completely free of charge. Orders will usually ship in 7-12 days. Order your tests now so you have them when you need them.
Remember the symptoms
The Centers for Disease Control and Prevention (CDC) reports that people with COVID-19 have had a wide range of symptoms reported — from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus.
Anyone can have mild to severe symptoms. People with the following symptoms may have COVID-19:
*Fever or chills
*Shortness of breath or difficulty breathing
*Muscle or body aches
*New loss of taste or smell
*Sore throat
*Congestion or runny nose
*Nausea or vomiting
This list does not include all possible symptoms.
CDC will continue to update the list as they learn more about COVID-19. Older adults and people who have severe underlying medical conditions like heart or lung disease or diabetes seem to be at higher risk for developing more serious complications from COVID-19 illness.
Please do not visit the emergency department for testing or for symptoms or reasons that do not require emergent care.
General information
For general COVID-19 questions, call 1-800-270-7268 or email Telephone calls are answered from 8 a.m. to 5 p.m., Monday through Friday, excluding holidays.
Interpreters are available. For frequently asked questions and to check your symptoms, visit the COVID-19 Information Hub at
K-12 Update
The K-12 school guidance was updated on January 13, 2022, and can be found at the following link:
Alabama-specific updates are currently in progress and will be posted to the Alabama Department of Public Health’s website ( as they are available.
Additionally, the Early Care and Education / Child Care Programs guidance was updated on January 28, 2022, and can be found at the following link:
Finally, the guidance for Institutions of Higher Education was updated on February 7, 2022, and can be found at the following link:
Those involved in decision-making in the situations for schools, child care and higher education are encouraged to view the resources linked above.